Genetic Polymorphisms of Metabolic Enzymes and the Pharmacokinetics of Indapamide in Taiwanese Subjects-Reference-Cited by-同舟云学术

Genetic Polymorphisms of Metabolic Enzymes and the Pharmacokinetics of Indapamide in Taiwanese Subjects

Published:2013-12-20 Issue:2 Volume:16 Page:206-213
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Wang Teng-Hsu,Hsiong Cheng-Huei,Ho Hsin-Tien,Shih Tung-Yuan,Yen San-Jan,Wang Hui-Hung,Wu Jer-Yuarn,Kuo Benjamin Pei-Chung,Chen Yuan-Tsong,Ho Shung-Tai,Hu Oliver Yoa-Pu

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-013-9535-x.pdf

Reference35 articles.

1. Lee C, Morton CC. Structural genomic variation and personalized medicine. N Engl J Med. 2008;358(7):740–1.

2. Ma MK, Woo MH, McLeod HL. Genetic basis of drug metabolism. Am J Health Syst Pharm. 2002;59(21):2061–9.

3. Wang KS, Zahn LE, Favor J, Huang KM, Stambolian D. Genetic and phenotypic analysis of T cm, a mutation affecting early eye development. Mamm Genome. 2005;16(5):332–43.

4. Sakurai Y, Hirayama M, Hashimoto M, Tanaka T, Hasegawa S, Irie S, et al. Population pharmacokinetics and proton pump inhibitory effects of intravenous lansoprazole in healthy Japanese males. Biol Pharm Bull. 2007;30(12):2238–43.

5. Tomalik-Scharte D, Lazar A, Fuhr U, Kirchheiner J. The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J. 2008;8(1):4–15.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent and Interactive Effects of Sex and CYP2C9 Variant rs4918758 on Ischemic Stroke Risk in Taiwan Biobank;International Journal of General Medicine;2022-04

2. Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2021-06-29

3. Sulfamethoxazole-trimethoprim-induced liver injury and genetic polymorphisms of NAT2 and CYP2C9 in Taiwan;Pharmacogenetics and Genomics;2021-06-18

4. The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients;Medicine;2020-03

5. Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment;Journal of Chromatography B;2019-07